IP Library Granted Patent US 11,938,171
Granted Patent B2
US 11,938,171 · App. 17/545,178 · Granted Mar 26, 2024

Therapeutic systems, devices, and compositions with wound healing and tissue regenerative properties, uses thereof, and corresponding methods

Inventor: Margaret V. Kalmeta (Irvine, CA)
Assignee: THE BIOREGENTECH INSTITUTE, INC.
A61K38/39A61K31/7004A61K31/728A61K33/26A61K33/34A61N5/06G06T7/0012H01S3/06708A61N2005/0632A61N2005/0652A61N5/067G06T2207/20212G06T2207/30088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,938,171
App. No.
17/545,178
Granted
Mar 26, 2024
Kind
B2
Abstract

Presented herein are compositions that can be administered to a subject having damaged tissue, for example a wound. The compositions are often administered in combination with administration of energy (e.g., laser energy, light from a light emitting diode, radiofrequency (RF) energy, audio frequency energy, etc.) from an energy generating device and/or system to the affected site. The compositions, systems, devices, and methods herein were found to induce wound healing and tissue regeneration.

Claims (29)

1. A composition with wound healing and tissue regenerative properties, the composition comprising:

a. collagen

b. hyaluronic acid

c. copper chloride or nano particle copper,

d. iron chloride or nano particle iron,

f. silver, and

e. gold

wherein the collagen is present in the composition in a range of 0.01-0.5% (wt/wt), the hyaluronic acid is present in the composition in a range of 0.1-1.5% (wt/wt), the copper chloride or nano particle copper is present in the composition in a range of 0.00001%-15% (wt/wt), the iron chloride or nano particle iron is present in the composition in a range of 0.00001%-15% (wt/wt), the silver is present in the composition in a range of 0.00001%-15% (wt/wt), and the gold is present in the composition in a range of 0.00001%-15% (wt/wt).

2. The composition of claim 1 , wherein the collagen comprises collagen fibers.

3. The composition of claim 1 , wherein the collagen comprises partially or completely hydrolyzed collagen.

4. The composition of claim 1 , wherein the collagen is acid treated collagen.

5. The composition of claim 1 , wherein the composition has a pH in a range of 1-8, 1 to 4, or 2 to 3.

6. The composition of claim 1 , wherein the composition comprises a water content in a range of 0 to 90%, 0% to 20%, or 0% to 10%, or 0% to 5% (wt/wt).

7. The composition of claim 1 , wherein a ratio of the hyaluronic acid to the silver is about 10-50,000 to 1.

8. The composition of claim 1 , wherein the silver comprises silver chloride or nano particle silver.

9. A composition with wound healing and tissue regenerative properties, the composition comprising:

a. collagen

b. hyaluronic acid

c. copper,

d. iron, and

f. silver

wherein the collagen is present in the composition in a range of 0.01-0.5% (wt/wt), the hyaluronic acid is present in the composition in a range of 0.1-1.5% (wt/wt), the copper is present in the composition in a range of 0.01%-0.1% (wt/wt) and the iron is present in the composition in a range of 0.01%-0.1% (wt/wt).

10. A composition with wound healing and tissue regenerative properties, the composition comprising:

a. collagen

b. hyaluronic acid

c. copper,

d. iron, and

e. silver,

wherein the collagen is present in the composition in a range of 0.01-0.5% (wt/wt), the hyaluronic acid is present in the composition in a range of 0.1-1.5% (wt/wt), the copper is present in the composition in a range of 0.00001%-15% (wt/wt), the iron is present in the composition in a range of 0.00001%-15% (wt/wt), and the silver is present in the composition in a range of 0.00001%-15% (wt/wt).

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT APPLICATION NO. 17/545179 TO THE CORRECT APPLICATION NO. 17545178 PREVIOUSLY RECORDED AT REEL: 060751 FRAME: 0708. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 17, 2022
From: BIOREGENTECH INC.
To: THE BIOREGENTECH INSTITUTE, INC.
Reel/Frame 061476/0663 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2022
From: BIOREGENTECH INC.
To: THE BIOREGENTECH INSTITUTE, INC.
Reel/Frame 060774/0884 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2022
From: BIOREGENTECH INC.
To: THE BIOREGENTECH INSTITUTE, INC.
Reel/Frame 060751/0708 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2021
From: KALMETA, MARGARET V.
To: BIOREGENTECH, INC.
Reel/Frame 058333/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2021
From: KALMETA, MARGARET V.
To: BIOREGENTECH, INC.
Reel/Frame 058384/0258 →
Continuity (4)
Continuation 16989808 · Aug 10, 2020
Provisional Application 62992579 · Mar 20, 2020
Provisional Application 62885761 · Aug 12, 2019
Related Publication 20220096605A1 · Mar 31, 2022